HLA-C and neoplasm: Recent data also demonstrate that ICOS-expressing CD4 are restricted to the tumor stroma, where the majority of MHCII-expressing cells are located31, suggesting that this response does not rely on direct antigen presentation by cancer cells, despite the impact of radiation on MHC expression by cancer cells5.